Novo Nordisk Rises, Centrica Gains, Inditex Up

On this episode of Stock Movers:

- Novo Nordisk received an upgrade to buy from hold at Berenberg, which switches its preferences within the obesity sector to make the Danish company its top pick instead of Eli Lilly.

- Morgan Stanley upgraded Centrica's stock to an overweight, or buy, rating. Their analyst made Centrica the new top pick within UK utilities. The shares aren’t even fully valuing its existing business, let alone potential upside from deals including Sizewell C and the Grain LNG terminal, a note said.

- Inditex gained to outperform peers as UBS raised the recommendation on the Zara owner to buy from neutral. Analysts at UBS said they felt confident in its long term growth following a strong start to the autumn-winter season.

See omnystudio.com/listener for privacy information.